Evidence map›Paper›PMID 34489167›Full record

ReviewTrends in immunology2021

Emerging roles of Dectin-1 in noninfectious settings and in the CNS.

M Elizabeth Deerhake, Mari L Shinohara

Open access · greenAbstract readReview
In one paragraph

Review in Trends in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Microglial dectin-1/Frontiers in immunology · 2026
    Article
  12. Article
  13. Review
  14. Microglial CLEC7A restrains amyloid beta plaque pathology in a mouse model of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M Elizabeth DeerhakeDepartment of Immunology, Duke University School of Medicine, Durham, NC 27705, USA.
Mari L ShinoharaDepartment of Immunology, Duke University School of Medicine, Durham, NC 27705, USA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27705, USA. Electronic address: mari.shinohara@duke.edu.
Duke University · US

Funding

Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6M
Role of osteopontin in innate immunity during infections and inflammationR01AI088100 · NIAID · DUKE UNIVERSITY · PI SHINOHARA, MARI L. · 2011 to 2021
$4.3M
Heterogeneous immune responses of the alveolar macrophage population during pulmonary fungal infectionsR01AI160737 · NIAID · DUKE UNIVERSITY · PI SHINOHARA, MARI L. · 2021 to 2025
$2.7M
Protective role of Clec7a/dectin-1 in CNS autoimmunityR01NS120417 · NINDS · DUKE UNIVERSITY · PI SHINOHARA, MARI L. · 2021 to 2025
$2.0M
Mechanism to evade host immunity by Mucorales fungiR21AI135999 · NIAID · DUKE UNIVERSITY · PI SHINOHARA, MARI L. · 2018 to 2019
$434k
Protective role of dectin-1 signaling in an animal model of Multiple SclerosisF30AI140497 · NIAID · DUKE UNIVERSITY · PI DEERHAKE, MARION ELIZABETH · 2018 to 2021
$169k
NIAID NIH HHS F30 AI140497NIAID NIH HHS R01 AI088100NIAID NIH HHS R01 AI160737NIAID NIH HHS R21 AI135999NIGMS NIH HHS T32 GM145449NINDS NIH HHS R01 NS120417
6 · The paper itself

Abstract

Dectin-1 is a C-type lectin receptor (CLR) expressed on the surface of various mammalian myeloid cells. Dectin-1 recognizes β-glucans and elicits antifungal proinflammatory immune responses. Recent studies have begun to examine the biology of Dectin-1 in previously less explored settings, such as homeostasis, sterile inflammation, and in the central nervous system. Indeed, in certain contexts, Dectin-1 is now known to promote tolerance, and anti-inflammatory and neuroprotective responses. In this review, we provide an overview of the current understanding of the roles of Dectin-1 in immunology beyond the context of fungal infections, mainly focusing on in vivo neuroimmunology studies, which could reveal new therapeutic approaches to modify innate immune responses in neurologic disorders.

Indexed as

beta-GlucansLectins, C-TypeAnimalsCentral Nervous SystemDectin-1Immunity, Innatebeta-GlucansDectin-1Lectins, C-TypeAlzheimer’s diseaseCARD9central nervous system (CNS)Clec7aDectin-1disease-associated microglia (DAM)experimental autoimmune encephalomyelitis (EAE)fungal infectionszymosan

Identifiers

PMID34489167
PMCPMC8487984
OpenAlexW3197958064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.